As shown in Fig. 1G, the IHC staining intensity of ELTD1 was notably different in different grades of glioma, and a quantification analyses further indicated that ELTD1 protein expression was significantly elevated in high-grade cancer (III + IV) (Fig. 1H, P < 0.01). The gene discussed is ADGRL4; the disease is central nervous system cancer.